- $89.14m
- $229.86m
- $25.26m
- 55
- 72
- 27
- 51
Annual income statement for Phenixfin, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | 2025 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 32.3 | 15.5 | 20.1 | 22.2 | 25.3 |
| Cost of Revenue | |||||
| Gross Profit | 25.4 | 10.4 | 14.6 | 15.6 | 15 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 13.9 | 12.4 | 13.6 | 17.4 | 20.1 |
| Operating Profit | 18.4 | 3.14 | 6.51 | 4.73 | 5.14 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 1.28 | -6.11 | 26.9 | 18.6 | 4.16 |
| Net Income After Taxes | 1.28 | -6.11 | 26.9 | 18.6 | 4.16 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 1.28 | -6.11 | 26.9 | 18.6 | 4.16 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 1.28 | -6.11 | 26.9 | 18.6 | 4.16 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.523 | -2.5 | 12.9 | 9.13 | 2.06 |
| Special Dividends per Share |